Selegiline tablets
Company: Teva Pharmaceutical
Approval Status: Approved January 1997
Treatment for: Parkinson’s disease
Areas: Neurology
General Information
Other Useful Resources
Selegiline has been approved for the treatment of Parkinson's disease. Selegiline is a generic equivalent of Somerset’s Eldepryl tablets, a drug for the treatment of Parkinson’s disease. Other generic versions of this product have been introduced over the last several months.
The FDA drug information shown here is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
